Author:
Ramaswamy Bhuvaneswari,Mrozek Ewa,Kuebler John Philip,Bekaii-Saab Tanios,Kraut Eric H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference19 articles.
1. Adjei AA, Charron M, Rowinsky EK et al (1998) Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II. Clin Cancer Res 4:683–691
2. Sebolt J, Havlick M, Hamelehle K et al (1989) Activity of the pyrazoloacridines against multidrug-resistant tumor cells. Cancer Chemother Pharmacol 24:219–224
3. Sebolt JS, Scavone SV, Pinter CD et al (1987) Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro. Cancer Res 47:4299–4304
4. Grem JL, Politi PM, Berg SL et al (1996) Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells. Biochem Pharmacol 51:1649–1659
5. Jackson RC, Sebolt JS, Shillis JL et al (1990) The pyrazoloacridines: approaches to the development of a carcinoma-selective cytotoxic agent. Cancer Invest 8:39–47
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献